Junichi Ikeda,Shunji Ichikawa,Masako Kurokawa,Tomoyuki Kanda
申请号：
US13055005
公开号：
US09254283B2
申请日:
2009.07.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided are therapeutic and/or preventive agents for migraine which comprise, as an active ingredient, a compound having a selective adenosine A2A receptor antagonistic activity or a pharmaceutically acceptable salt thereof therapeutic and/or preventive agents for migraine which comprise, as an active ingredient, a compound having a selective adenosine A2A receptor antagonistic activity, which has an affinity for the adenosine A2A receptor 10 times or higher than that for the adenosine A1 receptor, or a pharmaceutically acceptable salt thereof and the like.
